|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
WednesdayCHROMOS: monoclonal antibody (CHR-1103) that may be helpful in controlling acute exacerbations in MS
"CHROMOS TO MANUFACTURE MS DRUG CANDIDATE FOR TOXICOLOGY STUDIES AND CLINICAL TRIAL USING ACE SYSTEM"
Press Release: The manufacture and testing of a monoclonal antibody (CHR-1103) that may be helpful in controlling acute exacerbations in MS |